1. Home
  2. DIT vs IVVD Comparison

DIT vs IVVD Comparison

Compare DIT & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIT
  • IVVD
  • Stock Information
  • Founded
  • DIT 1981
  • IVVD 2020
  • Country
  • DIT United States
  • IVVD United States
  • Employees
  • DIT N/A
  • IVVD N/A
  • Industry
  • DIT Food Distributors
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • DIT Consumer Discretionary
  • IVVD Health Care
  • Exchange
  • DIT Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • DIT 78.7M
  • IVVD 69.0M
  • IPO Year
  • DIT 1995
  • IVVD 2021
  • Fundamental
  • Price
  • DIT $116.50
  • IVVD $0.78
  • Analyst Decision
  • DIT
  • IVVD Strong Buy
  • Analyst Count
  • DIT 0
  • IVVD 3
  • Target Price
  • DIT N/A
  • IVVD $7.52
  • AVG Volume (30 Days)
  • DIT 228.0
  • IVVD 2.5M
  • Earning Date
  • DIT 04-18-2025
  • IVVD 05-15-2025
  • Dividend Yield
  • DIT 0.62%
  • IVVD N/A
  • EPS Growth
  • DIT N/A
  • IVVD N/A
  • EPS
  • DIT 2.44
  • IVVD N/A
  • Revenue
  • DIT $2,221,421,072.00
  • IVVD $36,688,000.00
  • Revenue This Year
  • DIT N/A
  • IVVD $606.63
  • Revenue Next Year
  • DIT N/A
  • IVVD $83.30
  • P/E Ratio
  • DIT $47.80
  • IVVD N/A
  • Revenue Growth
  • DIT 7.47
  • IVVD N/A
  • 52 Week Low
  • DIT $99.87
  • IVVD $0.36
  • 52 Week High
  • DIT $166.00
  • IVVD $2.74
  • Technical
  • Relative Strength Index (RSI)
  • DIT 49.31
  • IVVD 57.49
  • Support Level
  • DIT $111.10
  • IVVD $0.64
  • Resistance Level
  • DIT $118.96
  • IVVD $1.09
  • Average True Range (ATR)
  • DIT 3.10
  • IVVD 0.11
  • MACD
  • DIT 0.27
  • IVVD 0.03
  • Stochastic Oscillator
  • DIT 75.26
  • IVVD 47.52

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: